drugset / Trial / NCT03357770

The Maximum Tolerated Dose of Mesenchymal Stem Cells From Umbilical Cord

NCT03357770

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study was to evaluate the maximum tolerated dose of Mesenchymal Stem Cells (MSCs) from umbilical cord in the treatment of human knee OA

Timeline

Start
2018-01-01
Primary completion
2020-12-01
Completion
2021-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy 1e+07 cells Other
Subject mesenchymal stem cells Cell therapy 5e+07 cells Other
Subject mesenchymal stem cells Cell therapy 1e+08 cells Other

Indications